Wird geladen...
Measurable residual disease in the treatment of chronic lymphocytic leukemia
Treatment outcomes of chronic lymphocytic leukemia (CLL) have improved since chemoimmunotherapy and novel drugs became available for CLL treatment; therefore, more sensitive methods to evaluate residual CLL cells in patients are required. Measurable residual disease (MRD) has been assessed in severa...
Gespeichert in:
| Veröffentlicht in: | J Clin Exp Hematop |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Japanese Society for Lymphoreticular Tissue Research
2020
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7810249/ https://ncbi.nlm.nih.gov/pubmed/33148932 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3960/jslrt.20014 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|